Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1999 Jan;80(1):F59–F63. doi: 10.1136/fn.80.1.f59

Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates

R A van Lingen, J Deinum, J Quak, A Kuizenga, J G van Dam, K Anand, D Tibboel, A Okken
PMCID: PMC1720876  PMID: 10325815

Abstract

AIM—To investigate the pharmacokinetics, metabolism, and dose-response relation of a single rectal dose of paracetamol in preterm infants in two different age groups. 
METHODS—Preterm infants stratified by gestational age groups 28-32 weeks (group 1) and 32-36 weeks (group 2) undergoing painful procedures were included in this study. Pain was assessed using a modified facies pain score. 
RESULTS—Twenty one infants in group 1 and seven in group 2 were given a single rectal dose of 20 mg/kg body weight. Therapeutic concentrations were reached in 16/21 and 1/7 infants in groups 1 and 2, respectively. Peak serum concentrations were significantly higher in group 1.Median time to reach peak concentrations was similar in the two groups. As serum concentration was still in the therapeutic range for some infants in group 1, elimination half life (T1/2) could not be determined in all infants: T1/2 was 11.0 ± 5.7in 11 infants in group 1 and 4.8 ± 1.2 hours in group 2. Urinary excretion was mainly as paracetamol sulphate. The glucuronide:sulphate ratio was 0.12 ± 0.09 (group 1) and 0.28 ± 0.35 (group 2). The pain score did not correlate with therapeutic concentrations.
CONCLUSIONS—A 20 mg/kg single dose of paracetamol can be safely given to preterm infants in whom sulphation is the major pathway of excretion. Multiple doses in 28-32 week old neonates would require an interval of more than 8 hours to prevent progressively increasing serum concentrations.



Full Text

The Full Text of this article is available as a PDF (126.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson G. M., Harman A. W. A role for the glutathione peroxidase/reductase enzyme system in the protection from paracetamol toxicity in isolated mouse hepatocytes. Biochem Pharmacol. 1989 Oct 1;38(19):3323–3330. doi: 10.1016/0006-2952(89)90630-8. [DOI] [PubMed] [Google Scholar]
  2. Alam S. N., Roberts R. J., Fischer L. J. Age-related differences in salicylamide and acetaminophen conjugation in man. J Pediatr. 1977 Jan;90(1):130–135. doi: 10.1016/s0022-3476(77)80787-7. [DOI] [PubMed] [Google Scholar]
  3. Anand K. J., Hickey P. R. Pain and its effects in the human neonate and fetus. N Engl J Med. 1987 Nov 19;317(21):1321–1329. doi: 10.1056/NEJM198711193172105. [DOI] [PubMed] [Google Scholar]
  4. Farr V., Mitchell R. G., Neligan G. A., Parkin J. M. The definition of some external characteristics used in the assessment of gestational age in the newborn infant. Dev Med Child Neurol. 1966 Oct;8(5):507–511. doi: 10.1111/j.1469-8749.1966.tb01796.x. [DOI] [PubMed] [Google Scholar]
  5. Felsher B. F., Maidman J. E., Carpio N. M., VanCouvering K., Woolley M. M. Reduced hepatic bilirubin uridine diphosphate glucuronyl transferase and uridine diphosphate glucose dehydrogenase activity in the human fetus. Pediatr Res. 1978 Aug;12(8):838–840. doi: 10.1203/00006450-197808000-00007. [DOI] [PubMed] [Google Scholar]
  6. Hartley R., Green M., Quinn M., Levene M. I. Pharmacokinetics of morphine infusion in premature neonates. Arch Dis Child. 1993 Jul;69(1 Spec No):55–58. doi: 10.1136/adc.69.1_spec_no.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hopkins C. S., Underhill S., Booker P. D. Pharmacokinetics of paracetamol after cardiac surgery. Arch Dis Child. 1990 Sep;65(9):971–976. doi: 10.1136/adc.65.9.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Johnston C. C., Stevens B. J., Yang F., Horton L. Differential response to pain by very premature neonates. Pain. 1995 Jun;61(3):471–479. doi: 10.1016/0304-3959(94)00213-X. [DOI] [PubMed] [Google Scholar]
  9. Lauterburg B. H., Vaishnav Y., Stillwell W. G., Mitchell J. R. The effects of age and glutathione depletion on hepatic glutathione turnover in vivo determined by acetaminophen probe analysis. J Pharmacol Exp Ther. 1980 Apr;213(1):54–58. [PubMed] [Google Scholar]
  10. Lederman S., Fysh W. J., Tredger M., Gamsu H. R. Neonatal paracetamol poisoning: treatment by exchange transfusion. Arch Dis Child. 1983 Aug;58(8):631–633. doi: 10.1136/adc.58.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levy G., Khanna N. N., Soda D. M., Tsuzuki O., Stern L. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. Pediatrics. 1975 Jun;55(6):818–825. [PubMed] [Google Scholar]
  12. Manne S. L., Jacobsen P. B., Redd W. H. Assessment of acute pediatric pain: do child self-report, parent ratings, and nurse ratings measure the same phenomenon? Pain. 1992 Jan;48(1):45–52. doi: 10.1016/0304-3959(92)90130-4. [DOI] [PubMed] [Google Scholar]
  13. McIntosh N. Pain in the newborn, a possible new starting point. Eur J Pediatr. 1997 Mar;156(3):173–177. doi: 10.1007/s004310050576. [DOI] [PubMed] [Google Scholar]
  14. Miller R. P., Roberts R. J., Fischer L. J. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther. 1976 Mar;19(3):284–294. doi: 10.1002/cpt1976193284. [DOI] [PubMed] [Google Scholar]
  15. Morselli P. L., Franco-Morselli R., Bossi L. Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clin Pharmacokinet. 1980 Nov-Dec;5(6):485–527. doi: 10.2165/00003088-198005060-00001. [DOI] [PubMed] [Google Scholar]
  16. Notarianni L. J., Oldham H. G., Bennett P. N. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. Br J Clin Pharmacol. 1987 Jul;24(1):63–67. doi: 10.1111/j.1365-2125.1987.tb03137.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Penna A., Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol. 1991 Aug;32(2):143–149. doi: 10.1111/j.1365-2125.1991.tb03873.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prescott L. F. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980 Oct;10 (Suppl 2):291S–298S. doi: 10.1111/j.1365-2125.1980.tb01812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rane A., Sjöqvist F., Orrenius S. Drugs and fetal metabolism. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):666–672. doi: 10.1002/cpt1973144part2666. [DOI] [PubMed] [Google Scholar]
  20. Rane A., Tomson G. Prenatal and neonatal drug metabolism in man. Eur J Clin Pharmacol. 1980 Jul;18(1):9–15. doi: 10.1007/BF00561473. [DOI] [PubMed] [Google Scholar]
  21. Rawlins M. D., Henderson D. B., Hijab A. R. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol. 1977 Apr 20;11(4):283–286. doi: 10.1007/BF00607678. [DOI] [PubMed] [Google Scholar]
  22. Roberts I., Robinson M. J., Mughal M. Z., Ratcliffe J. G., Prescott L. F. Paracetamol metabolites in the neonate following maternal overdose. Br J Clin Pharmacol. 1984 Aug;18(2):201–206. doi: 10.1111/j.1365-2125.1984.tb02453.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Rollins D. E., von Bahr C., Glaumann H., Moldéus P., Rane A. Acetaminophen: potentially toxic metabolite formed by human fetal and adult liver microsomes and isolated fetal liver cells. Science. 1979 Sep 28;205(4413):1414–1416. doi: 10.1126/science.38505. [DOI] [PubMed] [Google Scholar]
  24. Rumack B. H. Aspirin versus acetaminophen: a comparative view. Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):943–946. [PubMed] [Google Scholar]
  25. Rumore M. M., Blaiklock R. G. Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity. J Pharm Sci. 1992 Mar;81(3):203–207. doi: 10.1002/jps.2600810302. [DOI] [PubMed] [Google Scholar]
  26. Shannon M., Berde C. B. Pharmacologic management of pain in children and adolescents. Pediatr Clin North Am. 1989 Aug;36(4):855–871. doi: 10.1016/s0031-3955(16)36725-6. [DOI] [PubMed] [Google Scholar]
  27. Stevens H. M., Gill R. High-performance liquid chromatography systems for the analysis of analgesic and non-steroidal anti-inflammatory drugs in forensic toxicology. J Chromatogr. 1986 Nov 26;370(1):39–47. doi: 10.1016/s0021-9673(00)94672-7. [DOI] [PubMed] [Google Scholar]
  28. van den Anker J. N., Schoemaker R. C., Hop W. C., van der Heijden B. J., Weber A., Sauer P. J., Neijens H. J., de Groot R. Ceftazidime pharmacokinetics in preterm infants: effects of renal function and gestational age. Clin Pharmacol Ther. 1995 Dec;58(6):650–659. doi: 10.1016/0009-9236(95)90021-7. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES